Téléthon 2026 40th edition, Digi Mart USA News: The Téléthon returns on December 4 and 5, 2026, marking its 40th edition, with Patrick Fiori as godfather and thirty hours of fundraising on France Télévisions. According to the source, some children are now growing up with prospects their parents once could not imagine, while other families are still waiting for treatment or a diagnosis.
The program on Friday, December 4 at 6:45 p.m. on France 2 will bring together families, researchers, volunteers and artists for an anniversary edition.
The central question, according to the source, is how those still waiting can also benefit from the next advances in research.
Elena, a young woman with Crigler-Najjar syndrome, a rare genetic liver disease, previously relied on phototherapy lamps for long nightly treatment sessions. In 2023 she received an experimental gene therapy developed by Généthon as part of a clinical trial.
She says she no longer needs the lamps and sleeps better, and the source notes that the treatment remains experimental and is medically monitored.
Twin brothers Arthur and Raphaël have spinal muscular atrophy, a genetic disease affecting motor neurons. They received gene therapy at just fifteen days old and, according to testimonies and information published by AFM-Téléthon, are growing up without apparent symptoms and taking their first steps.
Their mother, Hélène, said, “Gene therapy saved our boys’ lives.”
Marie, 30, a middle school teacher and mother of a young daughter, also lives with spinal muscular atrophy. The source reports she has continued her studies, career and plans for a family, and that her treatment is described as stabilizing her condition.
Since September 1, 2025, spinal muscular atrophy has been part of France’s national newborn screening program.
Jean has Duchenne muscular dystrophy, diagnosed when he was three and a half years old. The source reports that Généthon’s candidate drug GNT0004 remains in clinical trials, with encouraging two-year results in three boys reported in March 2026, and that the next phase will assess the treatment in boys aged 6 to 10 who can still walk.
The source notes these results do not yet amount to a demonstrated cure.
Gabin, 8, has shown significant muscle weakness and motor difficulties since his first days, but the precise cause of his condition has not yet been identified. His family is going through a diagnostic odyssey, and AFM-Téléthon support helps them continue the search.
The source explains that gene therapy involves delivering genetic material to cells, often using a modified virus as a vector, to supply a functional copy of a gene or enable cells to produce a missing or malfunctioning protein. It also notes that treatments are disease-specific, that some are available while others remain in trials, and that not all rare diseases are genetic.
Patrick Fiori, godfather of Téléthon 2026, said his commitment has a personal history, as a close relative died without an available treatment. The broadcast will include reports featuring Elena, the twins, Anne Marivin, Romy and racing driver Charles Leclerc, with additional guests announced including Santa, Soprano and Vianney.
The program runs December 4 and 5, mainly on France 2, France 3 and france.tv, with the Saturday show continuing into the night of December 5 to 6. Two buses will carry local mobilizations to the studio in the Paris region, with arrival expected around 11 p.m.
on Saturday. A documentary, Téléthon, tout pour la vie, narrated by Zazie, is announced for Monday, November 30 at 11:10 p.m.
on France 3 and france.tv.
According to the source, the 2025 final collection totaled €100,548,314, and AFM-Téléthon notes that 95% of rare diseases remain without treatment. Donations can be made through don.telethon.fr, the 3637 line, and other channels described by the source.
Donors and the public can follow the broadcast to see how these stories and the search for treatments continue.
